Creating solutions, not products, in diabetes
Roche Diabetes Care’s Michael Goetzl explains how the company is spearheading a combined digital-pharmaceutical approach to diabetes and how pharma firms can best embrace holistic strategies.
Despite tremendous advances in medicine over the last few decades, the healthcare and pharma industries have not yet really managed to get diabetes under control.
“We are managing the disease as best as possible, but there could be much more progress in helping patients,” says Michael Goetzl, managing director UK & Ireland at Roche Diabetes Care.
Goetzl believes that combining pharmaceutical products with digital solutions can make this goal much more achievable.